Using Immunology & Genomics to Improve Diagnostic and Risk Management Precision

Women with PID are plagued by inadequate treatment in the United States in part because of the imprecision involved in the diagnosis of PID. Dr. Darville will discuss immunological translational research that has the potential to improve the precision associated with PID diagnosis and risk management in clinical settings.